BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29028811)

  • 21. Forkhead-box A1 transcription factor is a novel adverse prognosis marker in human glioma.
    Wang L; Qin H; Li L; Feng F; Ji P; Zhang J; Li G; Zhao Z; Gao G
    J Clin Neurosci; 2013 May; 20(5):654-8. PubMed ID: 23510544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between CacyBP/SIP expression and prognosis in astrocytoma.
    Zhao W; Wang C; Wang J; Ge A; Li Y; Li W; Lu Y
    J Clin Neurosci; 2011 Sep; 18(9):1240-4. PubMed ID: 21764585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular evidence of apoptotic death in malignant brain tumors including glioblastoma multiforme: upregulation of calpain and caspase-3.
    Ray SK; Patel SJ; Welsh CT; Wilford GG; Hogan EL; Banik NL
    J Neurosci Res; 2002 Jul; 69(2):197-206. PubMed ID: 12111801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Poly(adenosine diphosphate-ribose) polymerase 1 expression in malignant melanomas from photoexposed areas of the head and neck region.
    Staibano S; Pepe S; Lo Muzio L; Somma P; Mascolo M; Argenziano G; Scalvenzi M; Salvatore G; Fabbrocini G; Molea G; Bianco AR; Carlomagno C; De Rosa G
    Hum Pathol; 2005 Jul; 36(7):724-31. PubMed ID: 16084940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survivin subcellular localization in high-grade astrocytomas: simultaneous expression in both nucleus and cytoplasm is negative prognostic marker.
    Saito T; Arifin MT; Hama S; Kajiwara Y; Sugiyama K; Yamasaki F; Hidaka T; Arita K; Kurisu K
    J Neurooncol; 2007 Apr; 82(2):193-8. PubMed ID: 17151933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PARP-1 protein expression in glioblastoma multiforme.
    Galia A; Calogero AE; Condorelli R; Fraggetta F; La Corte A; Ridolfo F; Bosco P; Castiglione R; Salemi M
    Eur J Histochem; 2012 Feb; 56(1):e9. PubMed ID: 22472897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endothelin B receptor expression in human astrocytoma: association with clinicopathological variables and survival outcomes.
    Shen C; Yang L; Yuan X
    Int J Neurosci; 2011 Nov; 121(11):626-31. PubMed ID: 21770857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression and clinicopathological significance of Nck1 in human astrocytoma progression.
    Deshpande RP; Panigrahi M; Y B V K CS; Babu PP
    Int J Neurosci; 2019 Feb; 129(2):171-178. PubMed ID: 30146921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of integrin-linked kinase1 overexpression in astrocytoma.
    Li J; Zhang H; Wu J; Guan H; Yuan J; Huang Z; Li M
    Int J Cancer; 2010 Mar; 126(6):1436-44. PubMed ID: 19676046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and functional significance of ezrin in human brain astrocytoma.
    Mao J; Yuan XR; Xu SS; Jiang XC; Zhao XT
    Cell Biochem Biophys; 2013; 67(3):1507-11. PubMed ID: 23712870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The excitatory amino acid transporter-2 induces apoptosis and decreases glioma growth in vitro and in vivo.
    de Groot JF; Liu TJ; Fuller G; Yung WK
    Cancer Res; 2005 Mar; 65(5):1934-40. PubMed ID: 15753393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical expression of cycloxygenase-2 in astrocytoma: correlation with angiogenesis, tumor progression and survival.
    El-Sayed M; Taha MM
    Turk Neurosurg; 2011 Jan; 21(1):27-35. PubMed ID: 21294088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High nuclear poly-(ADP-ribose)-polymerase expression is prognostic of improved survival in pancreatic cancer.
    Klauschen F; von Winterfeld M; Stenzinger A; Sinn BV; Budczies J; Kamphues C; Bahra M; Wittschieber D; Weichert W; Striefler J; Riess H; Dietel M; Denkert C
    Histopathology; 2012 Sep; 61(3):409-16. PubMed ID: 22384823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-210 overexpression predicts poorer prognosis in glioma patients.
    Lai NS; Dong QS; Ding H; Miao ZL; Lin YC
    J Clin Neurosci; 2014 May; 21(5):755-60. PubMed ID: 24382515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. WT1 expression increases with malignancy and indicates unfavourable outcome in astrocytoma.
    Rauscher J; Beschorner R; Gierke M; Bisdas S; Braun C; Ebner FH; Schittenhelm J
    J Clin Pathol; 2014 Jul; 67(7):556-61. PubMed ID: 24607494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Geminin: a good prognostic factor in high-grade astrocytic brain tumors.
    Shrestha P; Saito T; Hama S; Arifin MT; Kajiwara Y; Yamasaki F; Hidaka T; Sugiyama K; Kurisu K
    Cancer; 2007 Mar; 109(5):949-56. PubMed ID: 17262828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cleavage of poly (ADP-ribose) polymerase-1 is involved in the process of porcine ovarian follicular atresia.
    Wei Q; Shi F
    Anim Reprod Sci; 2013 May; 138(3-4):282-91. PubMed ID: 23522430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Minichromosome maintenance protein 3 elicits a cancer-restricted immune response in patients with brain malignancies and is a strong independent predictor of survival in patients with anaplastic astrocytoma.
    Söling A; Sackewitz M; Volkmar M; Schaarschmidt D; Jacob R; Holzhausen HJ; Rainov NG
    Clin Cancer Res; 2005 Jan; 11(1):249-58. PubMed ID: 15671553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of 14-3-3 protein isoforms in human astrocytoma by immunohistochemistry.
    Cao L; Cao W; Zhang W; Lin H; Yang X; Zhen H; Cheng J; Dong W; Huo J; Zhang X
    Neurosci Lett; 2008 Feb; 432(2):94-9. PubMed ID: 18242847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-101 reverses hypomethylation of the PRDM16 promoter to disrupt mitochondrial function in astrocytoma cells.
    Lei Q; Liu X; Fu H; Sun Y; Wang L; Xu G; Wang W; Yu Z; Liu C; Li P; Feng J; Li G; Wu M
    Oncotarget; 2016 Jan; 7(4):5007-22. PubMed ID: 26701852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.